ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Guttmacher Named NICHD Director

December 18, 2009

GAO Criticizes Distribution Of Comprehensive Cancer Centers, Cite Needs for “Focal Point” Clarification

March 26, 1976

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

March 4, 1988

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007